5/4/03-
Three
months
into the
campaign,
only
some
35,000
healthcare
workers
have
received
the
Smallpox
innoculations
the
government
hopes
would
protect
them
from a
terrorist
attack
using
Smallpox.
Tommy
Thompson,
HHS
Secty.:
"35,000
is what
we have
right
now. We
would
like to
get
to
50,000."
But
health
officials,
who met
in
Washington
this
week to
check up
on the
program,
supported
the
slower
pace of
vaccinations.
Dr.
Brian
Strom,
Smallpox
committee
Chairman:
"To give
a
vaccine
against
a
disease
that
doesn't
exist,
particularly
a toxic
vaccine,
is
something
you want
to do
very
carefully
and very
slowly."
Senator
Susan
Collins
says the
slow
start
suggests
the
government
rushed
into
action
with too
many
unknowns.
The
innoculations
are also
proving
to be
more
expensive
than
predicted.
Senator
Susan
Collins:
"Originally,
the
Federal
Government
estimated
it would
cost
about $7
per
vaccination.
The
actual
cost has
varied
between
$79 and
over
$200.
That's a
significant
financial
burden."
There
have
been 68
cases of
adverse
effects
from the
Smallpox
vaccinations,
including
3 who
died
from
heart
attacks,
which
may be
linked
to the
innoculation.
But Dr.
Strom is
not
discouraged.
Dr.
Brian
Strom:
"What
the
Smallpox
vaccine
campaign
has done
is it
has led
to a
general
increase
in
public
health
preparedness,
and
that's
helped
us
enormously
in
multiple
other
events,
including
SARS."
In
fact,
the SARS
epidemic
has
given
the
government
a
glimpse
of what
could
happen
with an
outbreak
of
Smallpox.
A
frightened
public,
stepped-up
border
security,
isolation
of
victims.
Health &
Human
Services
Secretary
Tommy
Thompson
says
that's
all the
more
reason
to step
up the
pace of
Smallpox
innoculations.
Tommy
Thompson:
"Take a
look at
SARS.
The
healthcare
workers
became
very
sick
because
of SARS,
they
were not
protected.
The same
thing
would
happen
with
Smallpox."
And
health
officials
have
learned
another
lesson:
they may
not need
to
innoculate
as many
first
responders
as they
first
thought.
So
they're
turning
the
focus
away
from
sheer
numbers
to
specific
individuals
most
likely
to be
exposed
to the
disease
in a
terrorist
attack.